These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29203881)
21. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella? Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770 [TBL] [Abstract][Full Text] [Related]
22. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a. Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046 [TBL] [Abstract][Full Text] [Related]
23. Typhoid toxin sorting and exocytic transport from Chang SJ; Hsu YT; Chen Y; Lin YY; Lara-Tejero M; Galan JE Elife; 2022 May; 11():. PubMed ID: 35579416 [TBL] [Abstract][Full Text] [Related]
25. Emerging insights into the biology of typhoid toxin. Fowler CC; Chang SJ; Gao X; Geiger T; Stack G; Galán JE Curr Opin Microbiol; 2017 Feb; 35():70-77. PubMed ID: 28213043 [TBL] [Abstract][Full Text] [Related]
26. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines. Zuckerman JN; Hatz C; Kantele A Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever. Thakur R; Pathania P; Kaur N; Joshi V; Kondepudi KK; Suri CR; Rishi P Sci Rep; 2019 Dec; 9(1):18404. PubMed ID: 31804525 [TBL] [Abstract][Full Text] [Related]
28. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial. Kantele A; Pakkanen SH; Karttunen R; Kantele JM PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253 [TBL] [Abstract][Full Text] [Related]
29. The Majority of Typhoid Toxin-Positive Gaballa A; Cheng RA; Harrand AS; Cohn AR; Wiedmann M mSphere; 2021 Jan; 6(1):. PubMed ID: 33408236 [No Abstract] [Full Text] [Related]
30. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Wang JY; Noriega FR; Galen JE; Barry E; Levine MM Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868 [TBL] [Abstract][Full Text] [Related]
31. Vaccines for preventing typhoid fever. Milligan R; Paul M; Richardson M; Neuberger A Cochrane Database Syst Rev; 2018 May; 5(5):CD001261. PubMed ID: 29851031 [TBL] [Abstract][Full Text] [Related]
32. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae. Pakkanen SH; Kantele JM; Herzog C; Kantele A Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246 [TBL] [Abstract][Full Text] [Related]
33. Malnutrition and maternal vaccination against typhoid toxin. Neupane DP; Ahn C; Yang YA; Lee GY; Song J PLoS Pathog; 2022 Aug; 18(8):e1010731. PubMed ID: 35960787 [TBL] [Abstract][Full Text] [Related]
34. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses. Won G; Kim B; Lee JH Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314 [TBL] [Abstract][Full Text] [Related]
35. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. Salerno-Goncalves R; Pasetti MF; Sztein MB J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550 [TBL] [Abstract][Full Text] [Related]
36. Contribution of typhoid toxin in the pathogenesis of Salmonella Typhi. Thakur R; Suri CR; Rishi P Microb Pathog; 2022 Mar; 164():105444. PubMed ID: 35149176 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice. Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620 [TBL] [Abstract][Full Text] [Related]
39. Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model. Gibani MM; Jones E; Barton A; Jin C; Meek J; Camara S; Galal U; Heinz E; Rosenberg-Hasson Y; Obermoser G; Jones C; Campbell D; Black C; Thomaides-Brears H; Darlow C; Dold C; Silva-Reyes L; Blackwell L; Lara-Tejero M; Jiao X; Stack G; Blohmke CJ; Hill J; Angus B; Dougan G; Galán J; Pollard AJ Nat Med; 2019 Jul; 25(7):1082-1088. PubMed ID: 31270506 [TBL] [Abstract][Full Text] [Related]
40. Typhoid toxin provides a window into typhoid fever and the biology of Salmonella Typhi. Galán JE Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6338-44. PubMed ID: 27222578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]